Matinas BioPharma Holdings, Inc.
MTNB · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,251 | -$22,942 | -$20,997 | -$23,283 |
| Dep. & Amort. | $972 | $941 | $898 | $781 |
| Deferred Tax | -$84 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,195 | $4,948 | $0 | $4,292 |
| Change in WC | -$131 | $1,667 | -$4,789 | $1,535 |
| Other Non-Cash | $4,414 | $108 | $5,732 | $1,452 |
| Operating Cash Flow | -$15,885 | -$15,278 | -$19,156 | -$15,223 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$218 | -$892 | -$260 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$8,437 | $0 | -$9,481 | -$23,195 |
| Inv. Sales/Matur. | $17,645 | $13,460 | $15,250 | $40,225 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $9,208 | $13,242 | $4,877 | $16,770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$7 | -$20 | -$30 |
| Stock Issued | $9,179 | $0 | $99 | $5,580 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,415 |
| Financing Cash Flow | $9,174 | -$7 | $79 | $6,965 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,497 | -$2,043 | -$14,200 | $8,512 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,037 | $7,080 | $21,080 | $12,768 |
| End Cash | $7,534 | $5,037 | $6,880 | $21,280 |
| Free Cash Flow | -$15,885 | -$15,496 | -$20,048 | -$15,483 |